{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T02:05:59Z","timestamp":1779501959554,"version":"3.53.1"},"posted":{"date-parts":[[2026,5,20]]},"group-title":"Epidemiology","reference-count":49,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,5,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Lipoprotein(a) (Lp[a]) is a genetically determined causal and independent cardiovascular risk factor and Lp(a) targeted therapies are being developed. However, evidence on the safety of substantial Lp(a) lowering during pregnancy is limited. We evaluated the impact of Lp(a) lowering on adverse pregnancy and perinatal outcomes (APPOs) using human genetic evidence.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Material and Method<\/jats:title>\n                  <jats:p>\n                    We applied a drug-target Mendelian randomization (MR) approach using genetic variants associated with Lp(a) in the UK Biobank at the\n                    <jats:italic>LPA<\/jats:italic>\n                    locus to proxy pharmacological Lp(a) lowering. Summary-level APPO data were obtained from the MR-PREG collaboration, comprising up to 714,899 women across multiple studies. Twenty APPOs were included. Sensitivity analyses included adjustment for fetal genotype, alternative Lp(a) datasets, leave-one-study-out analyses, and exploration of Lp(a) genetic scores and individuals homozygous for\n                    <jats:italic>LPA<\/jats:italic>\n                    loss-of-function variants in the UK Biobank.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    Across 20 APPOs, MR estimates showed no strong evidence of causal effects, with no associations surviving false discovery rate\n                    <jats:italic>P<\/jats:italic>\n                    -value correction. Most estimates were close to null, including gestational hypertension, gestational diabetes, preeclampsia, miscarriage and neonatal intensive care unit admission. Some associations were slightly larger in magnitude but with wide confidence intervals: gestational age (mean difference 0.04 weeks, 95% CI 0.02\u20130.06 per 210nmol\/L reduction in Lp[a]) and congenital malformation (OR 0.82, 95% CI: 0.72\u20130.94) in the protective direction of effect, and higher odds of stillbirth (OR 1.09, 95% CI: 1.00\u2013 1.19) and low Apgar at 1 minute (OR 1.11, 95% CI: 0.99\u20131.24). Sensitivity analyses consistently supported the primary findings, with no evidence of increased maternal nor offspring risk in analyses adjusting for maternal\u2013 fetal genotype, across alternative exposure datasets, or in leave-one-study-out tests. Individual-level analyses of Lp(a) genetic score and\n                    <jats:italic>LPA<\/jats:italic>\n                    loss-of-function variants showed no associations, although power was limited.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These findings suggest that substantial lowering of Lp(a) is unlikely to increase APPO risk, although modest effects, particularly for rare outcomes, cannot be excluded.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.05.18.26351595","type":"posted-content","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:15:29Z","timestamp":1779326129000},"source":"Crossref","is-referenced-by-count":0,"title":["Using human genetic variation to estimate the effect of lipoprotein(a) lowering on pregnancy outcomes"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7549-6782","authenticated-orcid":false,"given":"Helena","family":"Urquijo","sequence":"first","affiliation":[{"name":"MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0345-1048","authenticated-orcid":false,"given":"Allison B","family":"Goldfine","sequence":"additional","affiliation":[{"name":"Translational Medicine, Biomedical Research, Novartis, Cambridge, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-6862","authenticated-orcid":false,"given":"Juan P","family":"Casas","sequence":"additional","affiliation":[{"name":"Translational Medicine, Biomedical Research, Novartis, Cambridge, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0161-3506","authenticated-orcid":false,"given":"Huilei","family":"Xu","sequence":"additional","affiliation":[{"name":"Translational Medicine, Biomedical Research, Novartis, Cambridge, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9100-2460","authenticated-orcid":false,"given":"Yoav","family":"Timsit","sequence":"additional","affiliation":[{"name":"Translational Medicine, Biomedical Research, Novartis, Cambridge, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-3958","authenticated-orcid":false,"given":"Mike","family":"Mendelson","sequence":"additional","affiliation":[{"name":"Translational Medicine, Biomedical Research, Novartis, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9871-7994","authenticated-orcid":false,"given":"Carolina","family":"Hache","sequence":"additional","affiliation":[{"name":"Translational Medicine, Biomedical Research, Novartis, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5490-5161","authenticated-orcid":false,"given":"Ieuan","family":"Jones","sequence":"additional","affiliation":[{"name":"Translational Medicine, Biomedical Research, Novartis, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0093-4839","authenticated-orcid":false,"given":"Daria","family":"Arustamian","sequence":"additional","affiliation":[{"name":"Translational Medicine, Biomedical Research, Novartis, Prague, Czechia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0568-3774","authenticated-orcid":false,"given":"Maria C","family":"Magnus","sequence":"additional","affiliation":[{"name":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0924-3247","authenticated-orcid":false,"given":"Tom R","family":"Gaunt","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"NIHR Bristol Biomedical Research Centre, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6793-2262","authenticated-orcid":false,"given":"Deborah A","family":"Lawlor","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-4547","authenticated-orcid":false,"given":"Maria Carolina","family":"Borges","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026052218451361000_2026.05.18.26351595v1.1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamacardio.2019.1041","article-title":"Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes","volume":"4","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026052218451361000_2026.05.18.26351595v1.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg8289"},{"key":"2026052218451361000_2026.05.18.26351595v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2022.04.006"},{"key":"2026052218451361000_2026.05.18.26351595v1.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.037184"},{"key":"2026052218451361000_2026.05.18.26351595v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad191"},{"key":"2026052218451361000_2026.05.18.26351595v1.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2415818"},{"key":"2026052218451361000_2026.05.18.26351595v1.7","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease","volume":"387","year":"2022","journal-title":"N. Engl. J. Med"},{"key":"2026052218451361000_2026.05.18.26351595v1.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.21957"},{"key":"2026052218451361000_2026.05.18.26351595v1.9","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/aogs.14972","article-title":"Cardiovascular disease in pregnancy: Prevalence and obstetric outcomes in a Swedish population-based cohort study between 2000 and 2019","volume":"103","year":"2024","journal-title":"Acta Obstet. Gynecol. Scand"},{"key":"2026052218451361000_2026.05.18.26351595v1.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac669"},{"key":"2026052218451361000_2026.05.18.26351595v1.11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0888-7543(03)00148-4","article-title":"Convergent evolution in primates and an insectivore","volume":"83","year":"2004","journal-title":"Genomics"},{"key":"2026052218451361000_2026.05.18.26351595v1.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.22.11992"},{"key":"2026052218451361000_2026.05.18.26351595v1.13","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3034"},{"key":"2026052218451361000_2026.05.18.26351595v1.14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2022.04.009","article-title":"Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis","volume":"349","year":"2022","journal-title":"Atherosclerosis"},{"key":"2026052218451361000_2026.05.18.26351595v1.15","doi-asserted-by":"publisher","DOI":"10.1111\/rssb.12388"},{"key":"2026052218451361000_2026.05.18.26351595v1.16","doi-asserted-by":"crossref","unstructured":"Shi J , Shringarpure SS , Hinds D , 23andMe Research Team, Auton A , Holmes MV . Evaluating genetically-predicted causal effects of lipoprotein(a) in human diseases: a phenome-wide Mendelian randomization study [Internet]. 2024 [cited 2025 May 1];Available from: http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.07.24.24310950","DOI":"10.1101\/2024.07.24.24310950"},{"key":"2026052218451361000_2026.05.18.26351595v1.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-103753"},{"key":"2026052218451361000_2026.05.18.26351595v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01839-y"},{"key":"2026052218451361000_2026.05.18.26351595v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41586023-06592-6"},{"key":"2026052218451361000_2026.05.18.26351595v1.20","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M076232"},{"key":"2026052218451361000_2026.05.18.26351595v1.21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","year":"2022","journal-title":"Nat. Rev. Methods Primer"},{"key":"2026052218451361000_2026.05.18.26351595v1.22","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21758"},{"key":"2026052218451361000_2026.05.18.26351595v1.23","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6835"},{"key":"2026052218451361000_2026.05.18.26351595v1.24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023184118"},{"key":"2026052218451361000_2026.05.18.26351595v1.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383"},{"key":"2026052218451361000_2026.05.18.26351595v1.26","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.22522"},{"key":"2026052218451361000_2026.05.18.26351595v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00757-z"},{"key":"2026052218451361000_2026.05.18.26351595v1.28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac361"},{"key":"2026052218451361000_2026.05.18.26351595v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3396"},{"key":"2026052218451361000_2026.05.18.26351595v1.30","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408"},{"key":"2026052218451361000_2026.05.18.26351595v1.31","doi-asserted-by":"crossref","unstructured":"Elsworth B , Lyon M , Alexander T , Liu Y , Matthews P , Hallett J , Bates P , Palmer T , Haberland V , Smith GD , et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv. 2020;2020.08.10.244293.","DOI":"10.1101\/2020.08.10.244293"},{"key":"2026052218451361000_2026.05.18.26351595v1.32","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303462"},{"key":"2026052218451361000_2026.05.18.26351595v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2024.06.005"},{"key":"2026052218451361000_2026.05.18.26351595v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(86)90150-2"},{"key":"2026052218451361000_2026.05.18.26351595v1.35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1042\/cs0880311","article-title":"Fetal and Maternal Lipoprotein Metabolism in Human Pregnancy","volume":"88","year":"1995","journal-title":"Clin. Sci"},{"key":"2026052218451361000_2026.05.18.26351595v1.36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","year":"2010","journal-title":"The Lancet"},{"key":"2026052218451361000_2026.05.18.26351595v1.37","doi-asserted-by":"publisher","DOI":"10.1080\/jmf.14.2.91.95"},{"key":"2026052218451361000_2026.05.18.26351595v1.38","first-page":"173","article-title":"Lipid and lipoprotein profile in physiological pregnancy","volume":"53","year":"2007","journal-title":"Clin. Lab"},{"key":"2026052218451361000_2026.05.18.26351595v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70642-8"},{"key":"2026052218451361000_2026.05.18.26351595v1.40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s42003-019-0444-0","article-title":"Chemical reprogramming enhances homology-directed genome editing in zebrafish embryos","volume":"2","year":"2019","journal-title":"Commun. Biol"},{"key":"2026052218451361000_2026.05.18.26351595v1.41","doi-asserted-by":"publisher","DOI":"10.1080\/00016340802085318"},{"key":"2026052218451361000_2026.05.18.26351595v1.42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/01443615.2019.1603214","article-title":"Correlation of elevated levels of lipoprotein(a), high-density lipoprotein and low-density lipoprotein with severity of preeclampsia: a prospective longitudinal study","volume":"40","year":"2020","journal-title":"J. Obstet. Gynaecol"},{"key":"2026052218451361000_2026.05.18.26351595v1.43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pcad.2025.07.012","article-title":"Lipoprotein(a) in pregnancy: A systematic review and meta-analysis","volume":"92","year":"2025","journal-title":"Prog. Cardiovasc. Dis"},{"key":"2026052218451361000_2026.05.18.26351595v1.44","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad655.2728"},{"key":"2026052218451361000_2026.05.18.26351595v1.45","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1160\/TH04-08-0519","article-title":"Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage","volume":"93","year":"2005","journal-title":"Thromb. Haemost"},{"key":"2026052218451361000_2026.05.18.26351595v1.46","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.fertnstert.2016.01.014","article-title":"Searching for a common mechanism for placenta-mediated pregnancy complications and cardiovascular disease: role of lipoprotein(a)","volume":"105","year":"2016","journal-title":"Fertil. Steril"},{"key":"2026052218451361000_2026.05.18.26351595v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00561-w"},{"key":"2026052218451361000_2026.05.18.26351595v1.48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113849"},{"key":"2026052218451361000_2026.05.18.26351595v1.49","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jacc.2021.01.051","article-title":"Emerging RNA Therapeutics to Lower Blood Levels of Lp(a)","volume":"77","year":"2021","journal-title":"J. Am. Coll. Cardiol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.05.18.26351595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T01:45:19Z","timestamp":1779500719000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.05.18.26351595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":49,"URL":"https:\/\/doi.org\/10.64898\/2026.05.18.26351595","relation":{},"subject":[],"published":{"date-parts":[[2026,5,20]]},"subtype":"preprint"}}